Class I histone deacetylase inhibition improves pancreatitis outcome by limiting leukocyte recruitment and acinar-to-ductal metaplasia.
Br J Pharmacol
; 174(21): 3865-3880, 2017 Nov.
Article
in En
| MEDLINE
| ID: mdl-28832971
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Pancreatitis
/
Autoimmune Diseases
/
Histone Deacetylase Inhibitors
/
Histone Deacetylases
Type of study:
Prognostic_studies
Limits:
Animals
Language:
En
Journal:
Br J Pharmacol
Year:
2017
Document type:
Article
Affiliation country:
Switzerland
Country of publication:
United kingdom